ProfileGDS4718 / 226165_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 90% 88% 94% 89% 91% 97% 97% 89% 86% 90% 91% 89% 95% 98% 97% 91% 91% 98% 96% 96% 89% 89% 90% 90% 91% 97% 90% 96% 88% 97% 91% 94% 87% 89% 98% 95% 97% 88% 87% 94% 89% 98% 92% 97% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.2906290
GSM549102patient 115, normal, homogenized [OPG study]8.7762888
GSM549104patient 119, normal, homogenized [OPG study]10.049194
GSM549108patient 138, normal, homogenized [OPG study]9.0137489
GSM549119patient 077, normal, homogenized [OPG study]9.4302991
GSM549133patient 032, cancer, homogenized [OPG study]11.036997
GSM549139patient 042, cancer, homogenized [OPG study]11.046297
GSM549099patient 107, normal, homogenized [OPG study]8.9162989
GSM549109patient 139, normal, homogenized [OPG study]8.5866886
GSM549110patient 046, normal, homogenized [OPG study]9.2971790
GSM549114patient 063, normal, homogenized [OPG study]9.5004891
GSM549122patient 082, normal, homogenized [OPG study]9.0257389
GSM549134patient 033, cancer, homogenized [OPG study]10.280195
GSM549136patient 036, cancer, homogenized [OPG study]11.228998
GSM549140patient 044, cancer, homogenized [OPG study]10.671197
GSM549111patient 047, normal, homogenized [OPG study]9.5466891
GSM549113patient 057, normal, homogenized [OPG study]9.4823191
GSM549132patient 031, cancer, homogenized [OPG study]11.104898
GSM549137patient 038, cancer, homogenized [OPG study]10.500196
GSM549142patient 047, cancer, homogenized [OPG study]9.9653596
GSM549100patient 110, normal, homogenized [OPG study]9.0482789
GSM549107patient 135, normal, homogenized [OPG study]9.0619889
GSM549115patient 068, normal, homogenized [OPG study]9.3299190
GSM549116patient 072, normal, homogenized [OPG study]9.3593690
GSM549120patient 078, normal, homogenized [OPG study]9.458691
GSM549131patient 030, cancer, homogenized [OPG study]11.085797
GSM549118patient 074, normal, homogenized [OPG study]9.2974990
GSM549129patient 027, cancer, homogenized [OPG study]10.433696
GSM549123patient 088, normal, homogenized [OPG study]8.8984288
GSM549124patient 006, cancer, homogenized [OPG study]10.722797
GSM549126patient 015, cancer, homogenized [OPG study]9.3407291
GSM549128patient 025, cancer, homogenized [OPG study]9.9491194
GSM549103patient 117, normal, homogenized [OPG study]8.5773787
GSM549117patient 073, normal, homogenized [OPG study]9.1577989
GSM549138patient 041, cancer, homogenized [OPG study]11.190998
GSM549141patient 045, cancer, homogenized [OPG study]10.246895
GSM549130patient 028, cancer, homogenized [OPG study]10.745197
GSM549101patient 111, normal, homogenized [OPG study]8.8259888
GSM549105patient 128, normal, homogenized [OPG study]8.7408687
GSM549106patient 134, normal, homogenized [OPG study]10.157894
GSM549112patient 048, normal, homogenized [OPG study]9.1308389
GSM549125patient 011, cancer, homogenized [OPG study]11.268198
GSM549127patient 024, cancer, homogenized [OPG study]9.500592
GSM549135patient 035, cancer, homogenized [OPG study]11.037197